Prelude Capital Management LLC boosted its position in shares of Sage Therapeutics, Inc. ( NASDAQ:SAGE – Free Report ) by 16.5% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 14,000 shares of the biopharmaceutical company's stock after purchasing an additional 1,978 shares during the quarter. Prelude Capital Management LLC's holdings in Sage Therapeutics were worth $587,000 as of its most recent filing with the Securities & Exchange Commission.

https://www.dailypolitical.com/2023/09/16/prelude-capital-management-llc-grows-stake-in-sage-therapeutics-inc-nasdaqsage.html

#dailypolitical